Blocking Growth: How Anti-Angiogenic Therapy Is Advancing Cancer Treatment
The Angiogenesis Therapeutic Agent Market is experiencing steady growth as anti-angiogenic therapy continues to advance cancer treatment and patient outcomes. According to market reports, the global Angiogenesis Therapeutic Agent Market was valued at USD 25.4 billion in 2024 and is projected to reach USD 37.8 billion by 2035, exhibiting a CAGR of 3.7% during the forecast period. This...
0 Comments 0 Shares 232 Views 0 Reviews